Special Offer: Get 50% off your first 2 months when you do one of the following
Personalized offer codes will be given in each session
Name
黃志基教授 Prof. Ian Wong
Title
香港大學藥理及藥劑學系系主任 Head of Department of Pharmacology & Pharmacy , The University of Hong Kong
Bio
香港大學藥理及藥劑學系系主任黃志基教授，在英國攻讀藥劑，畢業後成功研發出第一種獲歐盟兒童藥品銷售許可的兒科口服腦癇藥物。留英發展20多年後，黃教授決定於2011年回流香港，他多年來都醉心教學，又利用醫療大數據及臨床試驗方法進行不同的研究。
黃志基教授除了擔任香港大學藥理及藥劑學系系主任，還於香港政府重點項目InnoHK旗下的「醫衛大數據深析實驗室」擔任首席科學家。他與六十多位研究員組成科研團隊，跟世界各地的學術機構，甚至國際衞生機構合作。
黃教授除了利用大數據研究「專注力不足/過度活躍症」藥物在全球使用的情況外，亦分析新冠疫苗的安全性。2022年，黃教授更獲頒行政長官社區服務獎狀，表揚他在抗疫方面的貢獻。
Professor Ian Wong, Head of the Department of Pharmacology and Pharmacy at the University of Hong Kong, pursued his pharmacy studies in the UK where he successfully developed the first paediatric oral antiepileptic drug to receive a European Union Paediatric Use Marketing Authorisation. After spending over 20 years in the UK, Professor Wong decided to return to Hong Kong in 2011. He has a profound passion for teaching and has been conducting various research using medical big data and clinical trial methodologies.
In addition to his role at the University of Hong Kong, Professor Wong also serves as the Chief Scientist at the "Healthcare and Big Data Analysis Laboratory", a key project under the Hong Kong government's InnoHK initiative. He leads a research team of over sixty members, collaborating with academic institutions worldwide and even international health organizations.
Professor Wong not only utilizes big data to study the global usage of ADHD medications but also analyzes the safety of COVID-19 vaccines. In 2022, he was awarded the Chief Executive's Commendation for Community Service, recognizing his contributions to the fight against the pandemic.
黃志基教授除了擔任香港大學藥理及藥劑學系系主任，還於香港政府重點項目InnoHK旗下的「醫衛大數據深析實驗室」擔任首席科學家。他與六十多位研究員組成科研團隊，跟世界各地的學術機構，甚至國際衞生機構合作。
黃教授除了利用大數據研究「專注力不足/過度活躍症」藥物在全球使用的情況外，亦分析新冠疫苗的安全性。2022年，黃教授更獲頒行政長官社區服務獎狀，表揚他在抗疫方面的貢獻。
Professor Ian Wong, Head of the Department of Pharmacology and Pharmacy at the University of Hong Kong, pursued his pharmacy studies in the UK where he successfully developed the first paediatric oral antiepileptic drug to receive a European Union Paediatric Use Marketing Authorisation. After spending over 20 years in the UK, Professor Wong decided to return to Hong Kong in 2011. He has a profound passion for teaching and has been conducting various research using medical big data and clinical trial methodologies.
In addition to his role at the University of Hong Kong, Professor Wong also serves as the Chief Scientist at the "Healthcare and Big Data Analysis Laboratory", a key project under the Hong Kong government's InnoHK initiative. He leads a research team of over sixty members, collaborating with academic institutions worldwide and even international health organizations.
Professor Wong not only utilizes big data to study the global usage of ADHD medications but also analyzes the safety of COVID-19 vaccines. In 2022, he was awarded the Chief Executive's Commendation for Community Service, recognizing his contributions to the fight against the pandemic.
